Technical Analysis for GKOS - Glaukos Corporation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 20 DMA Support | Bullish | 1.41% | |
| MACD Bullish Signal Line Cross | Bullish | 1.41% | |
| New 52 Week Closing High | Bullish | 1.41% | |
| Expansion Breakout | Bullish Swing Setup | 1.41% |
| Alert | Time |
|---|---|
| Up 2% | about 23 hours ago |
| Possible Inside Day | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| Up 1% | 1 day ago |
| Down 3% | 1 day ago |
Get a Trading Assistant
- Earnings date: 05/01/2024
Glaukos Corporation Description
Glaukos Corporation (Glaukos) is an ophthalmic medical technology company. The Company is engaged in the development and commercialization of products and procedures for the treatment of glaucoma. Glaukos has developed the micro-invasive glaucoma surgery (MIGS) for glaucoma treatment. It offers iStent, an MIGS device measuring one millimeter long and 0.33 millimeter wide. MIGS procedures involve the insertion of a micro-scale device from within the eye's anterior chamber through a small corneal incision. Glaukos is also engaged in developing a portfolio of micro-scale injectable therapies, including three pipeline products, namely, the iStent Inject, the iStent Supra and iDose. The iStent Inject includes two stents pre-loaded in an auto-injection inserter. The iStent Supra is designed to access an alternative drainage space within the eye. iDose is an implant that is designed to provide a sustained release of a prostaglandin drug to lower intraocular pressure in glaucoma patients.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Eye Surgery Medical Technology Ophthalmology Ophthalmic Drainage Glaucoma Vision Implant Blindness Incision Treatment Of Glaucoma Eye Surgery Cornea Intraocular Pressure
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 108.22 |
| 52 Week Low | 54.3801 |
| Average Volume | 523,056 |
| 200-Day Moving Average | 80.14 |
| 50-Day Moving Average | 93.23 |
| 20-Day Moving Average | 99.28 |
| 10-Day Moving Average | 100.42 |
| Average True Range | 4.17 |
| RSI (14) | 69.04 |
| ADX | 20.29 |
| +DI | 30.10 |
| -DI | 13.93 |
| Chandelier Exit (Long, 3 ATRs) | 95.70 |
| Chandelier Exit (Short, 3 ATRs) | 105.70 |
| Upper Bollinger Bands | 104.88 |
| Lower Bollinger Band | 93.69 |
| Percent B (%b) | 1.15 |
| BandWidth | 11.28 |
| MACD Line | 2.47 |
| MACD Signal Line | 2.08 |
| MACD Histogram | 0.393 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 115.03 | ||||
| Resistance 3 (R3) | 114.33 | 110.79 | 113.61 | ||
| Resistance 2 (R2) | 110.79 | 108.62 | 111.14 | 113.14 | |
| Resistance 1 (R1) | 108.65 | 107.28 | 109.72 | 109.35 | 112.66 |
| Pivot Point | 105.11 | 105.11 | 105.65 | 105.46 | 105.11 |
| Support 1 (S1) | 102.97 | 102.94 | 104.04 | 103.67 | 100.36 |
| Support 2 (S2) | 99.43 | 101.60 | 99.78 | 99.88 | |
| Support 3 (S3) | 97.29 | 99.43 | 99.41 | ||
| Support 4 (S4) | 97.99 |
